Insights

Target discovery leverage Euretos Disease Atlas provides quantitative causal inference across thousands of indications with cell-type resolution, offering a powerful platform for biotech and pharma teams to accelerate target discovery and assessment, which can be pitched to build value in early drug development engagements.

Single-cell precision The platform emphasizes tissue- and cell-type level granularity using primary measurements, enabling partners to prioritize targets with higher causal biology signals and reduce downstream risk, a compelling value proposition for translational research and IND readiness discussions.

Evidence-based scoring Scores are tied to primary measurements with calibrated probabilities for causal biology, clinical reach, and approval, offering transparent, audit-ready outputs that can support regulatory discussions and external collaboration due diligence.

Recent funding momentum Recent news highlights grant funding for predictive personalised treatment and platform expansions, signaling credibility and growing capacity for large-scale collaborations, which can be leveraged to initiate co-development or funded partnership talks.

Expansion into collaboration tools Product updates such as the single-cell study viewer and workflow enhancements for orthologs and similar proteins indicate a willingness to broaden collaboration capabilities, presenting opportunities for joint research programs and platform integration with partner pipelines.

Similar companies to Euretos

Euretos Tech Stack

Euretos uses 8 technology products and services including Google Ads, LinkedIn Ads, Hotjar, and more. Explore Euretos's tech stack below.

Euretos's Email Address Formats

Euretos uses at least 2 email formats:
Euretos Email FormatsExamplePercentage
First.Last@euretos.comJohn.Doe@euretos.com
94%
First@euretos.comJohn@euretos.com
6%

Frequently Asked Questions

What is Euretos's official website and social media links?

Minus sign iconPlus sign icon
Euretos's official website is euretos.com and has social profiles on LinkedIn.

How much revenue does Euretos generate?

Minus sign iconPlus sign icon
As of October 2026, Euretos's annual revenue is estimated to be <$1M.

What is Euretos's SIC code and NAICS code?

Minus sign iconPlus sign icon
Euretos's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Euretos have currently?

Minus sign iconPlus sign icon
As of October 2026, Euretos has approximately 7 employees across 2 continents, including Europe and North America. Key team members include Ceo: A. K., Business Development (contract / Assignment): B. S. and Information Technology Management & Bash Script Developer: J. V. K. Explore Euretos's employee directory with LeadIQ.

What industry does Euretos belong to?

Minus sign iconPlus sign icon
Euretos operates in the Biotechnology Research industry.

What technology does Euretos use?

Minus sign iconPlus sign icon
Euretos's tech stack includes Google Ads, LinkedIn Ads, Hotjar, HubSpot Analytics, Matomo, HubSpot Content Hub, Open Graph and Microsoft 365.

What is Euretos's email format?

Minus sign iconPlus sign icon
Euretos's email format typically follows the pattern of First.Last@euretos.com. Find more Euretos email formats with LeadIQ.

When was Euretos founded?

Minus sign iconPlus sign icon
Euretos was founded in 2012.
Euretos logo

Euretos

Biotechnology ResearchUtrecht, Netherlands2-10 Employees

Euretos is a biotechnology research company based at 1 Yalelaan, Utrecht, Netherlands, and employs a small team of 2–10 people. The company provides a platform for data-driven translational research that enables researchers to understand disease mechanisms, identify drug targets, and evaluate pharmacological pathways without requiring bioinformatics or data science expertise. The platform integrates literature, patents, experimental data, clinical data, and real-world patient data into a large biological knowledge graph, comprising more than 4.5 billion statements, over 100 million publications and references, more than 2.5 million drug-related patents, and data from more than 100 multi-omics databases. It offers ready-to-use workflows for desk research, experiment design, and observation analysis, delivering insights from knowledge graph connections and supporting data-driven research and informed experimental and clinical trial design; it also provides AI-predicted gene-disease associations based on network biology. Recent updates include the May 2023 launch of Euretos Perspectives and other platform enhancements such as a 2022 single-cell study viewer and expanded target assessment workflows, reflecting ongoing development of its product offerings.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2012
Employees
2-10

Section iconFunding & Financials

  • <$1M

    Euretos's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.